LB973 11-year safety profile of genetically engineered autologous cell therapy in recessive dystrophic epidermolysis bullosa

Autor: Villanueva Gaona, R., Gorell, E.S., Marinkovich, M., Chiou, A., Wiss, K., Eid, E., Reusch, D., Truesdale, A., Abdelwahab, S., Tang, J.Y.
Zdroj: In Journal of Investigative Dermatology August 2024 144(8) Supplement:S171-S171
Databáze: ScienceDirect